BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 58 filers reported holding BIOTA PHARMACEUTIALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $240,000 | -22.6% | 160,000 | 0.0% | 0.12% | -29.1% |
| Q4 2015 | $310,000 | -2.2% | 160,000 | 0.0% | 0.16% | 0.0% |
| Q3 2015 | $317,000 | -4.2% | 160,000 | 0.0% | 0.16% | +3.1% |
| Q2 2015 | $331,000 | -10.1% | 160,000 | 0.0% | 0.16% | -4.2% |
| Q1 2015 | $368,000 | +2.8% | 160,000 | 0.0% | 0.17% | +5.7% |
| Q4 2014 | $358,000 | -9.4% | 160,000 | 0.0% | 0.16% | -29.8% |
| Q3 2014 | $395,000 | -99.9% | 160,000 | -28.9% | 0.22% | -26.5% |
| Q2 2014 | $641,000,000 | -25.0% | 225,000 | +60.7% | 0.31% | -21.3% |
| Q1 2014 | $855,000,000 | -28.4% | 140,000 | -50.9% | 0.39% | -28.8% |
| Q4 2013 | $1,194,000,000 | +0.3% | 285,000 | 0.0% | 0.55% | -5.4% |
| Q3 2013 | $1,191,000,000 | +21.2% | 285,000 | 0.0% | 0.58% | +49.5% |
| Q2 2013 | $983,000,000 | – | 285,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,407,700 | $3,153,000 | 0.92% |
| Broadfin Capital, LLC | 5,223,422 | $11,700,000 | 0.51% |
| Avoro Capital Advisors LLC | 258,586 | $579,000 | 0.39% |
| RA Capital Management | 1,378,770 | $3,088,000 | 0.33% |
| BVF INC/IL | 435,900 | $976,000 | 0.19% |
| Dominick & Dominick LLC | 150,166 | $336,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $358,000 | 0.16% |
| KNOTT DAVID M | 268,327 | $601,052,000 | 0.14% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $656,000 | 0.09% |
| Baker Brothers Advisors | 1,106,910 | $2,479,000 | 0.02% |